Annual report [Section 13 and 15(d), not S-K Item 405]

Cover

v3.25.2
Cover - USD ($)
 12 Months Ended
Jun. 30, 2025
Sep. 24, 2025
Dec. 31, 2024
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Jun. 30, 2025    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2025    
Current Fiscal Year End Date --06-30    
Entity File Number 001-42806    
Entity Registrant Name PROPANC BIOPHARMA, INC.    
Entity Central Index Key 0001517681    
Entity Tax Identification Number 33-0662986    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One 302    
Entity Address, Address Line Two 6 Butler Street    
Entity Address, City or Town Camberwell    
Entity Address, Country AU    
Entity Address, Postal Zip Code 3124    
City Area Code 61 03    
Local Phone Number 9882 0780    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 47,895
Entity Common Stock, Shares Outstanding   12,806,747  
Documents Incorporated by Reference [Text Block] None    
Document Financial Statement Error Correction [Flag] false    
Auditor Firm ID 106    
Auditor Opinion [Text Block] We have audited the accompanying consolidated balance sheets of Propanc Biopharma, Inc. and Subsidiary (the “Company”) as of June 30, 2025 and 2024, the related consolidated statements of operations and comprehensive income (loss), changes in stockholders’ deficit, and cash flows, for each of the two years in the period ended June 30, 2025, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as of June 30, 2025 and 2024 and the consolidated results of its operations and its cash flows for each of the two years in the period ended June 30, 2025, in conformity with accounting principles generally accepted in the United States of America.    
Auditor Name SALBERG & COMPANY, P.A.    
Auditor Location Boca Raton, Florida